Ophthalmic formulations including selective alpha 1 antagonists

Details Ophthalmic formulations including selective alpha 1 antagonists Ophthalmic formulations including selective alpha 1 antagonists

A - Human Necessities

61

K

A61K 31/66 (2006.01) A01N 57/00 (2006.01) G02B 27/10 (2006.01)

Patent

CA 2569468

Ophthalmic formulations are provided. The ophthalmic formulations include one or more active agents that act to optimize pupil light reflex while minimizing, or effectively eliminating, any undesired eye redness in response to application thereof. The active agents include, for example, alpha 1 antagonists, such as alpha 1a selective antagonists.

C'est invention concerne des formulations ophtalmiques, qui comprennent un ou plusieurs agents actifs qui servent à optimiser le réflexe pupillaire à la lumière tout en minimisant, ou en éliminant de façon efficace, toute rougeur indésirable de l'oeil en réponse à l'application de celles-ci. Les agents actifs comprennent, par exemple, des antagonistes des récepteurs alpha 1, tels que des antagonistes sélectifs des récepteurs alpha 1a.

Affiliated with

Also associated with

Rating

Ophthalmic formulations including selective alpha 1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic formulations including selective alpha 1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic formulations including selective alpha 1 antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1855567